Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan: Structural Requirements Differ from Those for Responses to Lipopolysaccharide
暂无分享,去创建一个
[1] R. Dziarski,et al. Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and Endotoxin* , 2000, The Journal of Biological Chemistry.
[2] R. Darveau,et al. CD14 Employs Hydrophilic Regions to “Capture” Lipopolysaccharides , 2000, The Journal of Immunology.
[3] J. Mathison,et al. Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide* , 2000, The Journal of Biological Chemistry.
[4] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[5] D. Golenbock,et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.
[6] M. Rothe,et al. Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.
[7] R. Dziarski,et al. Endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble CD14 but are activated indirectly by peptidoglycan-induced tumor necrosis factor-alpha and interleukin-1 from monocytes. , 1998, The Journal of infectious diseases.
[8] R. Tapping,et al. Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.
[9] R. Tapping,et al. Cellular Binding of Soluble CD14 Requires Lipopolysaccharide (LPS) and LPS-binding Protein* , 1997, The Journal of Biological Chemistry.
[10] H. Flad,et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.
[11] R. Dziarski,et al. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. , 1996, The Journal of infectious diseases.
[12] T. Kirkland,et al. CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.
[13] M. C. Hu,et al. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. , 1996, Journal of immunology.
[14] S. Wright,et al. Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein , 1996, The Journal of Biological Chemistry.
[15] J. Gegner,et al. Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.
[16] M. Kelley,et al. Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (*) , 1995, The Journal of Biological Chemistry.
[17] T. Kirkland,et al. A Region of Human CD14 Required for Lipopolysaccharide Binding (*) , 1995, The Journal of Biological Chemistry.
[18] H. Flad,et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.
[19] R. Dziarski,et al. Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. , 1994, The Journal of biological chemistry.
[20] M. Wurfel,et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.
[21] K. Kato,et al. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. , 1993, Journal of immunology.
[22] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[23] A. Ulmer,et al. Interactions of Bacterial Lipopolysaccharide and Peptidoglycan with Mammalian CD14 , 2002 .
[24] A. Ulmer,et al. Interactions of CD14 with components of gram-positive bacteria. , 2000, Chemical immunology.
[25] R. Menzel,et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. , 1997, European journal of biochemistry.
[26] R. Dziarski,et al. Isolation of peptidoglycan and soluble peptidoglycan fragments. , 1994, Methods in enzymology.